{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-04-01",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Miami",
      "state": "FL",
      "country": "United States",
      "classification": "Class III",
      "openfda": {},
      "product_type": "Food",
      "event_id": "85317",
      "recalling_firm": "Alfa Vitamins Laboratories, Inc.",
      "address_1": "4701 NW 77th Ave",
      "address_2": "N/A",
      "postal_code": "33166-5521",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit",
      "distribution_pattern": "Domestic distribution only.",
      "recall_number": "F-0926-2020",
      "product_description": "CALCI-MAX Dietary Supplement, 60 capsules, Manufactured for: DOMEL",
      "product_quantity": "1877 bottles",
      "reason_for_recall": "FDA sample analysis of Calci-Max lot 31453 showed the product zinc content to be 0.0% of label claim.",
      "recall_initiation_date": "20200324",
      "center_classification_date": "20200429",
      "termination_date": "20200825",
      "report_date": "20200506",
      "code_info": "LOT 31453  MFG 06 2019  EXP 06  2022"
    }
  ]
}